Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Priced IPO
Solaredge Technologies, Inc. (SEDG)
The Marygold Companies (MGLD)
Blue Water Vaccines (BWV)
Meihua International Medical Technologies (MHUA)
Smart for Life (SMFL)
Vivakor (VIVK)
TC BioPharm Holdings (TCBP)
Direct Digital Holdings, Llc (DRCT)
Modiv (MDV)
Sky Technologies (SKYX)
Modular Medical (MODD)
HeartCore Enterprises (HTCR)
Arcellx, Inc. (ACLX)
Silver Spike Investment Corp. (SSIC)
Maris-Tech Ltd. (MTEK)
Yoshitsu Co., Ltd. (TKLF)
Tpg Inc. (TPG)
Hillstream BioPharma (HILS)
Hour Loop (HOUR)
Vigil Neuroscience, Inc. (VIGL)
More companies

Evotec Se (EVO)

Sector - Healthcare

Price chart

N/A
Return from IPO

Company News

IPO Profile

About company

They are an industry-leading drug discovery and development partner for the pharmaceutical and biotechnology industry. Their mission is to discover best and first-in-class medicines for a broad range of difficult to treat diseases in collaboration with their partners. To that end, they have built a comprehensive suite of fully integrated, next generation technology platforms which they believe will transform the way new drugs are discovered. By leveraging the advanced capabilities of their integrated platforms, they are able to provide solutions to their partners that enable significant improvements in the quality of new drugs while accelerating the drug discovery process and reducing the high cost of attrition often associated with traditional drug discovery processes. They generate revenue primarily through three core collaboration routes: (1) by providing their drug discovery capabilities on a fee-for-service and FTE-rate basis; (2) by receiving milestones and royalties on assets; and (3) by creating value through equity ownership in emerging, highly innovative biotechnology companies and translational academic institutional projects. Contracts with their partners can include elements of one or more of their three core collaboration routes.
Industry
Pharmaceutical Preparations
CEO CFO
-
Employees Founded
3900 1993

Contacts

Address: Essener Bogen 7, 22419 Hamburg, Germany

Telephone: +49 40 560810

Web page: http://www.evotec.com

IPO information

First Trade Date 11/4/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 22
Shares Revised (MM) 20
Expected offer amount (MM) $575.52
Realized offer amount(MM) $435

Financial Data (last reporting year)

Market Cap (MM) $9187.4
Revenues (MM) $541.2
Net Income (Loss) (MM) $111.7

Voting

What do you think will happen with the EVO share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: BofA Securities

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
BofA Securities/ Morgan Stanley/ Citi/ Jefferies/ Cowen/ RBC Capital Markets
CO-Managers

Sector: Healthcare

Tweets about $EVO

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats